Researchers confirm 1st case of coronavirus reinfection in the U.S.

Contracting the coronavirus isn't just a one-time threat.
After it seemed some people who'd recovered from COVID-19 could contract the virus a second time, researchers in Hong Kong confirmed a reinfection for the first time earlier this week. Researchers in Nevada reported Friday that they'd also confirmed a reinfection in the U.S., and that the patient still experienced severe symptoms when contracting the virus again.
A 25-year-old Reno, Nevada, man tested positive for COVID-19 back in April after showing mild symptoms of the virus. He then tested positive for the virus again in May and developed more severe symptoms as a result of a second, separate infection, according to a study released Friday that has yet to be peer reviewed. The University of Nevada, Reno School of Medicine and the Nevada State Public Health Laboratory confirmed it wasn't just the first infection reemerging in this case because the second virus had a different genetic strain than the first.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The reinfection will have big implications for coronavirus vaccine developers worldwide, especially given how severe this case was compared to the one in Hong Kong. Promising vaccines have so far produced COVID-19 antibodies in human trials, but these cases of reinfection suggest the antibodies gained from catching COVID-19 don't necessarily guarantee immunity or even lessen the virus' symptoms the second time around.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
The Week Unwrapped: Why are sinkholes becoming more common?
Podcast Plus, will Saudi investment help create the "Netflix of sport"? And why has New Zealand's new tourism campaign met with a savage reception?
By The Week UK Published
-
How Poland became Europe's military power
The Explainer Warsaw has made its armed forces a priority as it looks to protect its borders and stay close to the US
By Elizabeth Carr-Ellis, The Week UK Published
-
Quiz of The Week: 15 - 21 February
Have you been paying attention to The Week's news?
By The Week Staff Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published